Historically, diagnostic testing has taken a one-size-fits-all approach: Doctors order tests, health professionals collect the sample, laboratorians conduct the assays, and results are sent back to ...

10 analysts have expressed a variety of opinions on Quest Diagnostics (NYSE:DGX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...

With its range of products, Veracyte displays a robust and diverse portfolio, targeting multiple areas in oncology. Veracyte's recent data underscores the company's innovative edge in the field of ...

In this episode, Laura Dyrda interviews Dr. Paul Kruszka, Clinical Geneticist at Children’s National Hospital in Washington, D.C. Dr. Kruszka shares insights into the latest advancements in genomic ...

Quest Diagnostics (NYSE:DGX) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Hologic’s HOLX Diagnostics unit, the largest by revenues, has been the most impacted by geopolitical headwinds this year. Cuts in USAID funding have affected its HIV testing business in Africa, while ...

Researchers have unlocked a way of sniffing out cancer in patients with very-early-stage pancreatic cancer. This time, instead of relying on dogs, the technology relies on the help of a much smaller ...

Companion diagnostics in fields like oncology are well-known, but it’s their potential impact on psychiatry that is gaining attention and has the potential to shape the future of the industry.

Co-Diagnostics CODX will release its quarterly earnings report on Thursday, 2025-05-08. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Co-Diagnostics to report an ...